Profile data is unavailable for this security.
About the company
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its formulation products include Divatrone, Maintane 500 injection, Maintane 250 injection, Maintane Tablet, Indocap capsules, Metadec 50 injection, Metadec 25 injection, EndoReg Tablet, LycoRed softgels, LycoRed syrup, Doxypal DR-L Capsule, Yuliprist Tablet, COLLA-2 Tablet, Cystelia M, and DeeReg Tablet, among others. Its OTC products include Ringcuter Cream, Skin Lumia Soap-Antibacterial, and Skin Lumia Soap-Neem Tulsi. Its Naari products include Endoreg, Yuliprist, Verena, Kyrah, Krampoff, Endonorm EV2, Divagest SR 300, Divagest SR 200, Cystelia 35, Fibristone 25, and Cystelia-M. Its other products include Lycored Softgels, Lycored Syrup, JP Tone Syrup, and Doxypal DR-L. The Company’s therapy areas include gynecology, orthopedics, and others.
- Revenue in INR (TTM)2.21bn
- Net income in INR245.16m
- Incorporated1978
- Employees940.00
- LocationJagsonpal Pharmaceuticals LtdT 210J, ShahpurjatNEW DELHI 110049IndiaIND
- Phone+91 1 126494519
- Fax+91 1 126494708
- Websitehttps://www.jagsonpal.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicamen Biotech Ltd | 1.71bn | 126.93m | 5.51bn | 388.00 | 44.32 | -- | 30.34 | 3.23 | 9.78 | 9.78 | 131.89 | -- | -- | -- | -- | 4,398,250.00 | -- | 7.17 | -- | 10.44 | 46.88 | 33.85 | 6.58 | 10.87 | -- | 4.76 | -- | 8.61 | 22.02 | 4.77 | -0.3555 | 7.98 | -4.21 | 0.00 |
| Kilitch Drugs (India) Ltd | 1.55bn | 145.71m | 5.65bn | 153.00 | 38.14 | -- | 35.03 | 3.65 | 9.21 | 9.21 | 98.24 | -- | -- | -- | -- | 10,132,730.00 | -- | 2.63 | -- | 3.59 | 39.68 | 33.85 | 8.25 | 5.01 | -- | 3.43 | -- | 2.93 | 22.20 | 22.30 | 41.82 | 15.19 | 1.79 | -- |
| Albert David Ltd | 3.55bn | 662.42m | 6.84bn | 1.27k | 10.32 | -- | 9.30 | 1.93 | 116.07 | 116.07 | 621.75 | -- | -- | -- | -- | 2,791,696.00 | -- | 7.61 | -- | 10.17 | 64.33 | 60.21 | 18.67 | 8.47 | -- | 108.22 | -- | 16.18 | 8.95 | 3.40 | 2.60 | 21.82 | 6.81 | 10.35 |
| Valiant Laboratories Ltd | -100.00bn | -100.00bn | 6.95bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 60.35 | -- | 27.66 | -- | -- | -- |
| IND Swift Laboratories Ltd | 11.92bn | 431.95m | 7.31bn | 1.50k | 16.90 | -- | 7.81 | 0.6135 | 7.32 | 7.32 | 201.78 | -- | -- | -- | -- | 7,966,648.00 | -- | 0.5374 | -- | 0.6839 | 47.60 | 40.86 | 3.67 | 1.08 | -- | 2.27 | -- | 0.00 | 16.23 | 9.54 | 2,314.83 | 16.71 | -9.61 | -- |
| Nectar Lifesciences Ltd | 16.32bn | 80.79m | 7.62bn | 1.59k | 93.19 | -- | 11.06 | 0.4672 | 0.3649 | 0.3649 | 74.40 | -- | -- | -- | -- | 10,271,550.00 | -- | 0.0556 | -- | 0.1038 | 27.40 | 15.63 | 0.495 | 0.0707 | -- | 0.7366 | -- | 32.09 | -8.70 | -4.33 | -196.55 | -- | -1.95 | -- |
| Sakar Healthcare Ltd | 1.51bn | 124.73m | 7.83bn | 297.00 | 58.99 | -- | 26.80 | 5.19 | 6.10 | 6.10 | 73.58 | -- | -- | -- | -- | 5,082,286.00 | -- | 6.35 | -- | 7.59 | 46.18 | 44.28 | 8.26 | 10.84 | -- | 2.40 | -- | -- | 4.00 | 20.23 | -16.30 | 27.31 | 56.31 | -- |
| Panacea Biotec Ltd | 5.52bn | -119.17m | 8.46bn | 1.09k | -- | -- | 16.44 | 1.53 | -1.89 | -1.89 | 89.86 | -- | -- | -- | -- | 5,046,990.00 | -- | 10.52 | -- | 18.65 | 56.88 | 50.87 | -2.21 | 27.34 | -- | -- | -- | 0.00 | -30.44 | -5.06 | -103.08 | -- | 21.89 | -- |
| Jagsonpal Pharmaceuticals Ltd | 2.21bn | 245.16m | 8.61bn | 940.00 | 35.01 | -- | 32.77 | 3.90 | 9.30 | 9.30 | 83.51 | -- | -- | -- | -- | 2,347,522.00 | -- | 10.02 | -- | 12.51 | 54.09 | 58.47 | 11.11 | 8.03 | -- | 30.39 | -- | 36.24 | 8.79 | 13.33 | 41.72 | -- | -39.20 | 118.67 |
| Bajaj Healthcare Ltd | 4.98bn | 212.66m | 8.80bn | 1.06k | 41.36 | -- | 17.96 | 1.77 | 7.71 | -18.22 | 180.50 | -- | -- | -- | -- | 4,684,510.00 | -- | 9.86 | -- | 17.42 | 42.26 | 26.47 | 4.27 | 8.57 | -- | 1.66 | -- | -- | -0.9704 | 15.53 | -39.73 | 23.16 | 60.82 | 31.95 |
| Remus Pharmaceuticals Ltd | 450.27m | 85.03m | 10.18bn | 38.00 | 108.13 | 39.19 | 113.37 | 22.61 | 63.92 | 63.92 | 361.02 | 176.36 | -- | -- | -- | 11,849,290.00 | -- | -- | -- | -- | 52.39 | -- | 18.88 | -- | 1.35 | -- | 0.2933 | -- | 82.17 | -- | 151.14 | -- | -- | -- |
| Vimta Labs Ltd | 3.20bn | 413.41m | 10.60bn | 1.37k | 26.02 | -- | 14.04 | 3.31 | 18.37 | 18.37 | 142.48 | -- | -- | -- | -- | 2,342,054.00 | -- | 10.50 | -- | 12.94 | 75.80 | 72.82 | 12.90 | 11.92 | -- | 28.50 | -- | 12.37 | 14.34 | 11.64 | 16.55 | 24.00 | 15.39 | 0.00 |
| Windlas Biotech Ltd | 6.00bn | 526.38m | 11.46bn | 1.05k | 21.89 | -- | 17.34 | 1.91 | 25.18 | 25.18 | 286.98 | -- | -- | -- | -- | 5,723,394.00 | -- | -- | -- | -- | 37.06 | -- | 8.77 | -- | -- | 59.55 | -- | -- | 10.12 | -- | 11.91 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Motilal Oswal Asset Management Co. Ltd.as of 31 Mar 2024 | 103.00 | 0.00% |
